Clinical Trial Update: Evaluation the Treatment Outcome for RFA in Patients With BCLC Stage B HCC in Comparison With TACE [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial evaluating radiofrequency ablation vs transarterial chemoembolization for intermediate-stage hepatocellular carcinoma (BCLC stage B).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Fudan University | Conditions: Hepatocellular Carcinoma | Phase 2, Phase 3 | Status: UNKNOWN